In this episode:

• The importance of accurately diagnosing mild cognitive impairment early
• Lifestyle & CVD risk factor modification are important with the Mediterranean diet, and medical food Souvenaid showing benefits if taken daily for three years
• The importance of reducing the burden of anticholinergic agents being taken
• Soon there will be monoclonal antibody therapy aimed at reducing amyloid plaque, which has delayed progression of cognitive impairment, however accurate diagnosis will be required to access these agents
• We believe the patient can die with the disease, and not because of the disease

Expert: Prof Michael Woodward AM, Geriatrician

This podcast is intended to be medical advice that is designed for health professionals only. We do not recommend you use this podcast as a substitute for a consult with a qualified health professional.

See omnystudio.com/listener for privacy information.